Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Frankfurt - Delayed Quote EUR

Mesoblast Limited (LWB.F)

Compare
1.3900
-0.0300
(-2.11%)
At close: February 28 at 3:29:01 PM GMT+1
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
--
5,902
7,501
10,211
7,434
Operating Expense
--
63,874
76,790
91,318
115,037
Operating Income
--
-57,972
-69,289
-81,107
-107,603
Net Non Operating Interest Income Expense
--
-18,834
-18,613
-17,288
-10,714
Other Income Expense
--
-11,341
5,801
6,809
18,687
Pretax Income
--
-88,147
-82,101
-91,586
-99,630
Tax Provision
--
-191
-212
-239
-819
Net Income Common Stockholders
--
-87,956
-81,889
-91,347
-98,811
Diluted NI Available to Com Stockholders
--
-87,956
-81,889
-91,347
-98,811
Basic EPS
-8.91
-8.91
-10.53
-13.38
-0.15
Diluted EPS
-8.91
-8.91
-10.53
-13.38
-0.15
Basic Average Shares
1,141,241.2110
986,702.9190
777,719.0910
682,861.4250
638,179.5870
Diluted Average Shares
1,141,241.2110
986,702.9190
777,719.0910
682,861.4250
638,179.5870
Total Expenses
--
63,874
76,790
91,318
115,037
Net Income from Continuing & Discontinued Operation
--
-87,956
-81,889
-91,347
-98,811
Normalized Income
--
-76,639.5741
-87,675.0207
-98,138.2314
-117,344.3851
Interest Income
--
1,824
831
3
22
Interest Expense
--
20,658
19,444
17,288
10,714
Net Interest Income
--
-18,834
-18,613
-17,288
-10,714
EBIT
--
-67,489
-62,657
-74,298
-88,916
EBITDA
--
-62,823
-58,550
-69,918
-84,652
Reconciled Depreciation
--
4,666
4,107
4,380
4,264
Net Income from Continuing Operation Net Minority Interest
--
-87,956
-81,889
-91,347
-98,811
Total Unusual Items Excluding Goodwill
-11,341
-11,341
5,801
6,809
18,687
Total Unusual Items
-11,341
-11,341
5,801
6,809
18,687
Normalized EBITDA
--
-51,482
-64,351
-76,727
-103,339
Tax Rate for Calcs
--
0
0
0
0
Tax Effect of Unusual Items
--
-24.5741
14.9793
17.7686
153.6149
6/30/2021 - 1/26/2006

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

1VT.F Viking Therapeutics, Inc.
27.90
+2.35%
 
NGENF NervGen Pharma Corp.
1.9150
-0.26%
 
CNTB Connect Biopharma Holdings Limited
0.9099
+1.10%
 
PHRRF PharmaTher Holdings Ltd.
0.1420
+4.80%
 
KYTX Kyverna Therapeutics, Inc.
2.8400
+1.43%
 
LYRA Lyra Therapeutics, Inc.
0.2140
+5.52%
 
ATHE Alterity Therapeutics Limited
3.7800
-2.33%
 
ABEO Abeona Therapeutics Inc.
5.24
+1.95%
 
TSHA Taysha Gene Therapies, Inc.
1.6000
+0.63%
 
MURA Mural Oncology plc
3.6800
+0.55%